Eric Kelsic

Company: Dyno Therapeutics

Job title: Founder and Chief Executive Officer

Bio:

Prior to founding Dyno, Eric led a team to develop the technology underlying Dyno’s artificial intelligence powered capsid engineering platform in George Church’s lab at the Wyss Institute of Harvard Medical School. There he measured the first comprehensive fitness landscape of the adeno-associated virus (AAV) capsid protein and co-discovered the AAV MAAP gene.

Seminars:

Machine-Guided Design of AAV Capsids for Ocular & CNS Indications 1:40 pm

Highlighting the latest data for Dyno eCap 1 and bCap 1 vectors as ocular and CNS delivery vectors respectively Benchmarking progress with AI and ML approaches and applications Outlining a roadmap of these innovative vectors to reach the clinicRead more

day: Conference Day One